Articles and Blogs

On April 27, 2021, the Department of Health and Human Services (“HHS”) released new buprenorphine practice guidelines entitled, Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder (“Practice Guidelines”), that remove a longstanding requirement tied to practitioner training that has been cited as a barrier to treating larger numbers of individuals... READ MORE

Until today, the United States Drug Enforcement Agency (the “DEA”) has prohibited telemedicine prescribing of controlled substances unless the provider had previously seen the patient in a traditional in‑person physical encounter, or under other various narrow circumstances. But today, the DEA invoked their emergency authority at 21 U.S.C. § 802(54)(D) to permit telemedicine prescribing... READ MORE

The USDA Hemp Producer License Rule and Framework On October 31, 2019, the United States Department of Agriculture (“USDA”) published an interim final rule[1] with request for comments in the Federal Register regarding hemp production (“USDA Hemp Rule” or the “Interim Final Rule”).[2] The USDA Hemp Rule establishes a federal hemp producer license and... READ MORE